(Q39320082)

11 September 2017

title

Coagulative and fibrinolytic properties of ascitic fluid associated with ovarian tumors (English)

2 references

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

11 September 2017

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

author name string

L. Svanberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47263

6 April 2022

B. Astedt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A47263

6 April 2022

language of work or name

English

0 references

publication date

1 May 1975

1 reference

full work available at URL

11 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

1 reference

11 September 2017

volume

35

1 reference

11 September 2017

issue

5

1 reference

11 September 2017

page(s)

1382-1387

1 reference

The fibrin plate method for estimating fibrinolytic activity

11 September 2017

cites work

2

40

346

Astrup

1952

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Release of fibrinolytic activators from human tumours cultured in vitro

6 April 2022

5

28

833

Björlin

1972

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

6

16

542

Böck

1970

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Fibrinolytic activity of human tumors as measured by the fibrin-plate method

6 April 2022

7

8

1146

Cliffton

1955

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Plasminogen-activator-producing Tumour

6 April 2022

8

88

Davidson

1969

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Mechanism of the Proteolytic Activity of Malignant Tissue Cells

6 April 2022

series ordinal

11

volume

157

0 references

Determination of alpha-2-macroglobulin as trypsin-protein esterase

12

14

493

Ganrot

1966

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Immunochemical determination of human plasminogen

6 April 2022

13

22

335

Ganrot

1968

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Clinical experience with determination of fibrinogen degradation products

6 April 2022

14

189

471

Hedner

1971

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

On the use of fibrinolysin inhibitors in plasma clot tissue culture

6 April 2022

15

21

232

Ingemanson-Nordqvist

1961

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies

6 April 2022

17

15

45

Laurell

1966

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time.

6 April 2022

19

159

35

Nilsson

1957

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin

6 April 2022

22

3

201

Owren

1951

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

A method for determining serum inhibitors of plasminogen activation

6 April 2022

23

14

138

Paraskevas

1962

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

DNA content of mucinous tumors of the ovary

6 April 2022

26

103

1023

Weiss

1969

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

A modification for routine laboratory use of Stefanini's method of estimating factor V activity in human oxalated plasma

6 April 2022

27

6

34

Wolf

1953

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

Fibrin degradation products and ovarian tumours.

6 April 2022

28

458

Åstedt

1971

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

29

1312

Åstedt

1972

1 reference

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

https://api.crossref.org/works/10.1002/1097-0142(197505)35:5%3C1382::AID-CNCR2820350522%3E3.0.CO;2-0

6 April 2022

Identifiers

10.1002/1097-0142(197505)35:5<1382::AID-CNCR2820350522>3.0.CO;2-0

1 reference

11 September 2017

1 reference